Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.

OBJECTIVE: To compare the incidence of anti-double-stranded DNA (anti-dsDNA) antibodies in rheumatoid arthritis (RA) patients receiving either single or multiple doses of a chimeric anti-tumor necrosis factor alpha (anti-TNFalpha) antibody or placebo infusions, with or without methotrexate, in open-...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Charles, P, Smeenk, R, De Jong, J, Feldmann, M, Maini, R
Định dạng: Journal article
Ngôn ngữ:English
Được phát hành: 2000